T. Rowe Price Investment Management’s ICU Medical ICUI Stock Holding History

T. Rowe Price Investment Management’s Portfolio ICUI Stock Details ICUI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-17	Closed	-$3K	–	785
2025 Q4	$3K	Sell	17 -198	-92%	-$26.5K	﹤0.01%	847
2025 Q3	$26K	Sell	215 -128	-37%	-$16.2K	﹤0.01%	672
2025 Q2	$46K	Buy	+343	New	+$46.5K	﹤0.01%	664
2024 Q1	–	Sell	-442,403	Closed	-$44.1M	–	637
2023 Q4	$44.1M	Sell	442,403 -1,875,671	-81%	-$183M	0.03%	401
2023 Q3	$276M	Sell	2,318,074 -72,323	-3%	-$10.8M	0.2%	132
2023 Q2	$426M	Sell	2,390,397 -28,967	-1%	-$5.31M	0.29%	103
2023 Q1	$399M	Sell	2,419,364 -3,864	-0.2%	-$665K	0.29%	99
2022 Q4	$382M	Sell	2,423,228 -55,633	-2%	-$8.47M	0.29%	96
2022 Q3	$373M	Buy	+2,478,861	New	+$412M	0.3%	95

Other funds holding ICUI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

RRAM

River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Investment Management's ICUI Position: Q1 2026 in Review

T. Rowe Price Investment Management sold out of ICU Medical (ICUI) in Q1 2026, closing a stake of 17 shares — an estimated $3K sold.

T. Rowe Price Investment Management first reported a position in ICUI in Q3 2022 and held it in 9 quarters. The position peaked at $426M in Q2 2023. 275 funds tracked by Wall St. Rank hold ICUI as of Q1 2026.

T. Rowe Price Investment Management reported no remaining ICU Medical position as of Q1 2026 after selling out during the quarter.
T. Rowe Price Investment Management sold 17 ICU Medical shares in Q1 2026, an estimated $3K.
T. Rowe Price Investment Management first reported a position in ICU Medical in Q3 2022 and held it in 9 quarters.
T. Rowe Price Investment Management's ICU Medical position peaked at $426M in Q2 2023.
275 funds tracked by Wall St. Rank held ICU Medical as of Q1 2026.

Based on T. Rowe Price Investment Management's 13F filing for Q1 2026, filed 15 May 2026.